PKM2的形态动力学调节低氧诱导的病态视网膜血管生成
Peiwen Zhu1,2,3, Hao Chang1,2,3, Qian Yang1,2,3
1Department of Ophthalmology and Vision Science, Eye and Ear, Nose and Throat Hospital of Fudan University, Shanghai, People's Republic of China.
Investigative ophthalmology & visual science
|December 5, 2025
概括
在视网膜新血管化过程中对酸盐激酶M2 (PKM2) 的研究表明,其结构变化推动了疾病的进展. 用DASA-58激活PKM2四分体抑制了病态血管生成,为诸如早产儿视网膜病变等疾病提供了潜在的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 抗血管内皮生长因子 (VEGF) 疗法对于视网膜新血管化并不总是有效的.
- 酸盐激酶M2 (PKM2) 在瘤生长中至关重要,但其在视网膜血管生成中的作用尚不清楚.
- 了解新的途径对于治疗视网膜神经血管疾病至关重要.
研究的目的:
- 探索PKM2形状动态在病态视网膜新血管化中的作用.
- 为了研究PKM2的结构如何影响视网膜血管生成在低氧条件下.
主要方法:
- 使用氧气诱导视网膜病变 (OIR) 的小鼠模型和暴露于缺氧的人类视网膜微血管内皮细胞 (HRMECs).
- 通过使用DASA-58,PKM2四重化的一种小分子激活剂,评估了PKM2的结构动力学.
主要成果:
- 缺氧诱导PKM2单体化,核转位和与HIF-1α相互作用,促进血管性基因表达.
- DASA-58治疗促进了PKM2四聚体的形成,抑制了核转位,抑制了HIF-1α信号传递,并减少了视网膜新血管化.
- 在体内,DASA-58治疗减少了新血管化,血管泄漏,保持了视网膜厚度,并改善了OIR小鼠的视觉功能.
结论:
- PKM2的结构动力学代表了低氧诱导的视网膜新血管化的新型调节机制.
- 通过DASA-58诱导PKM2四聚体的形成,为新血管性眼病提供了潜在的治疗策略,包括早产视网膜病变 (ROP).
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K